Concepts behind the development of multiple drug therapy regimens in leprosy
Waters, M.F.
Ethiopian Medical Journal 24(Suppl 1): 61-67
1986
ISSN/ISBN: 0014-1755 PMID: 3301332 Document Number: 283831
Document emailed within 1 workday
Related Documents
Mitulescu, D.; Selaru, D.; Ocian, R. 1999: Drug therapy regimens in diabetic retinopathy Oftalmologia 46(1): 63-66Seydel, J.K. 1990: Drugs and drug development for chemotherapy of leprosy and tuberculosis, including M. avium infections Tropical Medicine and Parasitology: Official Organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft für Technische Zusammenarbeit 41(3): 341-343
Kaur, S.; Sharma, V.K.; Kumar, B.; Singh, M.; Kaur, I. 1985: Multi-drug therapy in bacilliferous leprosy--two years experience Indian Journal of Leprosy 57(3): 483-490
Zhang, M.; Han, X.-X.; Cui, W.-G.; Jia, M.-H.; Meng, X.-D.; Xing, A.-H.; Wu, Y.-H.; Yang, Y.-Y.; Lu, C.-M.; Hu, Q.-H.; Dai, D.; Zhang, Z.-N.; Shang, H. 2008: The impacts of current antiretroviral therapy regimens on Chinese AIDS patients and their implications for HIV-1 drug resistance mutation Japanese Journal of Infectious Diseases 61(5): 361-365
Cartel, J.C.; Gallais, J.J.; Naudillon, Y.; Millan, J.; Grosset, J.H. 1986: 5-year assessment of daily multi-drug therapy of leprosy in Guadeloupe since 1980 Acta Leprologica 4(4): 415-425
Dousset-Faure, I.; Millan, J.; Decazes, J.M.; Languillon, J. 1986: Clinical and bacteriological assessment 8 years after triple-drug therapy for multibacillary leprosy in Senegal Acta Leprologica 4(4): 465-472
Otomo, E. 1988: Drug therapy of Alzheimer's disease. General concepts on nootropic drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 46(7): 1569-1574
Khalimov, I.S.; Matveev, S.I.; Kuz'min, V.G.; Vetriakov, O.V. 2013: Prospective concepts of the military field therapy development Voenno-Meditsinskii Zhurnal 334(6): 36-42
Duvivier, C.; Ghosn, J.; Assoumou, L.; Soulié, C.; Peytavin, G.; Calvez, V.; Génin, M.èl.A.é; Molina, J.-M.; Bouchaud, O.; Katlama, C.; Costagliola, D.; Beucler, I.; Dion, E.; Raffi, F.; Delfraissy, J.F.; Commoy, M.J.; Massip, P.; Garraffo, R.; Mazetier, L.; Izopet, J.; Chêne, G.; Racheline, A.; Jarousse, B.; Abgrall, S.; Obenga, G.; Phung, B.; Gerbe, J.; Bentata, M.; Honoré, P.; Rami, A.; Delcey, V.; Drener, M.; Parrinello, M.; Miailhes, P.; Lebouche, B.; Kouadjo, K.; Benmakhlouf, N.; Goujard, C.; Miquel, A.; Quetainmont, Y.; Rannou, M.T.; Perronne, C.; de Truchis, P.; Berthé, H.; Jeantils, V.; Tassi, S.; Rozenbaum, W.; Slama, L.; Chakvetaze, C.; Galanaud, P.; Boué, F.; Delavalle, A.M.; Lefebvre, B.; Bollens, D.; Meynard, J.L.; Oua 2008: Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial Journal of Antimicrobial ChemoTherapy 62(4): 797-808
Kulkarni, S.K.; Naidu, P.S. 2003: Pathophysiology and drug therapy of tardive dyskinesia: current concepts and future perspectives Drugs of Today 39(1): 19-49
Nebout, M. 1983: Current therapeutics in leprosy: resistance--therapeutic regimens--control strategy Acta Leprologica 1(3): 151-158
O'hara, H.; Yamamoto, H. 2018: A Case of a Patient with Rectum Cancer with Multiple Metastases, who Was Able to Undergo Conversion Therapy Using Alternating mFOLFOX6 and FOLFIRi Regimens in Combination with Alternating Cetuximab and Bevacizumab Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(11): 1669-1672
Sakurai, T.; Jinta, E.; Suzuma, T.; Yoshimura, G.; Umemura, T.; Sakurai, T. 2012: Bi-weekly nab-paclitaxel and trastuzumab therapy effective against recurrent breast cancer with multiple lung metastases in elderly patient who had previously undergone two chemotherapeutic regimens for treatment of metastatic disease-a case Report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(11): 1703-1706
Malviya, G.N. 2014: Disabilities in leprosy--The new concepts Indian Journal of Leprosy 86(3): 121-127
Hauzeur, A.C. 1960: Towards the eradication of leprosy ? Influence of ambulatory treatment of leprosy with DADPS, on the progression of the leprosy epidemic and its results Additional note concerning the existent reports between leprosy and allergy to tuberculin and the prophylactic value of BCG Ann Soc Beige Med Trop: 115-167
Hauzeur, A.C. 1960: Towards the eradication of leprosy ? Influence of ambulatory treatment of leprosy with DADPS, on the progression of the leprosy epidemic and its results Additional note concerning the existent reports between leprosy and allergy to tuberculin and the prophylactic value of BCG Ann Soc Beige Med Trop: 115-167
Le Page, E.; Edan, G. 2006: Drug therapy in multiple sclerosis La Revue du Praticien 56(12): 1336-1346
David, N.A.; Welborn, W.S.; Pierce, H.I. 1975: Comparison of multiple and combination tablet drug therapy in hypertension Current Therapeutic Research 18(6): 741-754
García de la Osa, M.de.la.Paz.; García Silvera, E.; Solano Leal, M.; Milanés Virelles, Mía.Teresa. 2012: Response to therapy in multiple drug resistant tuberculosis patients Revista Cubana de Medicina Tropical 64(2): 153-162
Con, I.; Daiber, A.; Donoso, A.; Osorio, G.; Mora, F. 1972: Multiple drug therapy in Hodgkin's disease, lymphosarcoma and reticulosarcoma Revista Medica de Chile 100(4): 408-413